Published in AIDS Weekly, March 6th, 2000
Under the terms of the collaboration, the International AIDS Vaccine Initiative (IAVI) will fund development, preclinical, and Phase I studies of the vaccine at Targeted Genetics and at Columbus, Ohio-based Children's Research Institute, the statement said.
In June 1999,...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.